CAS: 56883-39-7; 2-Azido-2-Deoxy-D-Glucose

该化合物是一种经修改的葡萄糖,第二碳的氢氧基组被一个Azido组(-N3)取代.该化合物被归类为单沙酸,是碳水化合物家族的一部分.其分子结构保留了六人组成的基本葡萄糖环特征,但Azido组的存在具有独特的化学特性,使其在各种生物化学应用中有用,特别是在生物合成和标签研究中.Azido组以其在化学中的再活动而著称,允许与含有烷的分子有选择性的反应.D-Glucose, 2-azido-2-deoxy-通常在水中溶解,与其他糖类似,并可以参与各种因存在功能组而产生的化学反应.其CAS编号为56883-39-7,是一个独特的识别指标,便于在化学数据库和文献中识别.

结构式图片

欧盟法规

ECHA物质C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2014303363-A1
    优先权日:2011-12-09
    标题 :Preparation and Use of Isolactosamine and Intermediates therefor
    发明人:HEDEROS MARKUS; RISINGER CHRISTIAN; BOUTET JULIEN; DEKANY GYULA
    权利人:GLYCOM AS
    摘要:The invention relates to providing isolactosamine (Galβ1-3GlcNH 2 , formula 1) and salts thereof in the form of either anomer or mixture thereof, as well as hydrates or solvates of the free base and salts thereof. The synthesis of isolactosamine and its use in the synthesis of lacto-N-biose containing oligosaccharides are also disclosed.

    专利号:US-10183962-B2
    优先权日:2014-02-25
    标 题:Synthetic oligomers of Neisseria meningitis serogroup X and process of preparing them
    发明人:GILL DAVINDER; HARALE KISHORE; CHHIKARA MANOJ KUMAR
    权利人:MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD
    摘要:The present invention relates to synthesis of novel higher oligomers and process of preparing the same. In particular the present invention relates to the chemical synthesis of oligomers of Neisseria meningitidis serogroup X (‘hereinafter Men-X), more particularly tetramer. The present invention provides Men-X capsular oligomers obtained from synthetic pathway using purified saccharides of specific chain length and provides said novel oligomers as candidates for the development of conjugate vaccine against bacterial meningitis caused due to Men-X infections.

    专利号:US-2023212216-A1
    优先权日:2019-12-20
    标 题:Synthesis of lactone derivatives and their use in the modification of proteins
    发明人:MORRIS ALEXANDER REDFERN; SUTOV GRIGORIJ; BRUNE KARL DIETRICH
    权利人:GENIE BIOTECH UK LTD
    摘要:Site-specific modifications of proteins are desirable in biotechnological applications such as biopharmaceuticals, immunotherapy, vaccines, and are useful in chemical biology. Gluconoylation is a non-enzymatic, covalent, post-translational modification commonly observed on N-terminal His-Tags bearing proteins. We synthesized glucono-1,5-lactone derivatives, including azido variants for selective acylation. High yield acylation is achieved by simply mixing derivatives with target protein amidst diverse conditions of temperatures, aqueous buffers, excipients, or complex cell lysate.

    专利号:AU-2020409711-A1
    优先权日:2019-12-20
    标题 :Synthesis of lactone derivatives and their use in the modification of proteins

    专利号:EP-4076533-A1
    优先权日:2019-12-20
    标 题:Synthesis of lactone derivatives and their use in the modification of proteins

    专利号:US-2017016040-A1
    优先权日:2011-07-21
    标题:Chemoenzymatic synthesis of heparin and heparan sulfate analogs
    淄博飞阳生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chemfy.com/
    电话: 0533-7866336 13573361699👤
    📞淄博飞阳生物科技有限公司 ⚠️参考联系方式

    销售电话:0533-7866336 13573361699
    邮箱:sales@chemfy.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/8904_2015_501
    摘要:Choi Y, Tuzikov AB, Ovchinnikova TV, Bovin NV, Pshezhetsky AV. Novel Direct Assay for Acetyl-CoA:α-Glucosaminide N-Acetyltransferase Using BODIPY-Glucosamine as a Substrate. JIMD Rep. 2015 Oct 23;().
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知